Patent 11643689 was granted and assigned to DermTech International on May, 2023 by the United States Patent and Trademark Office.
Disclosed herein are methods of detecting an altered gene expression levels in a subject suspected of having atopic dermatitis. Further described herein are methods of treating atopic dermatitis in a subject having an exhibiting an altered gene expression level.